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Graphical abstract
Co- infection of Galleria mellonella larvae with Staphylococcus aureus and Candida albicans results in enhanced proliferation and 
virulence of S. aureus compared with mono- infection with S. aureus.
Abstract
This study detailed the responses of Galleria mellonella larvae to disseminated infection caused by co- infection with Candida 
albicans and Staphylococcus aureus. Doses of C. albicans (1×105 larva−1) and S. aureus (1×104 larva−1) were non- lethal in mono- 
infection but when combined significantly (P<0.05) reduced larval survival at 24, 48 and 72 h relative to larvae receiving S. 
aureus (2×104 larva−1) alone. Co- infected larvae displayed a significantly higher density of S. aureus larva−1 compared to larvae 
infected solely with S. aureus. Co- infection resulted in dissemination throughout the host and the appearance of large nodules. 
Co- infection of larvae with C. albicans and S. aureus (2×104 larva−1) resulted in an increase in the density of circulating haemo-
cytes compared to that in larvae infected with only S. aureus. Proteomic analysis of co- infected larval haemolymph revealed 
increased abundance of proteins associated with immune responses to bacterial and fungal infection such as cecropin- A 
(+45.4- fold), recognition proteins [e.g. peptidoglycan- recognition protein LB (+14- fold)] and proteins associated with nodule 
formation [e.g. Hdd11 (+33.3- fold)]. A range of proteins were also decreased in abundance following co- infection, including 
apolipophorin (−62.4- fold), alpha- esterase 45 (−7.7- fold) and serine proteinase (−6.2- fold). Co- infection of larvae resulted in 
enhanced proliferation of S. aureus compared to mono- infection and an immune response showing many similarities to the 
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InTRoduCTIon
The human microbiome consists of communities of bacteria, 
archaea, viruses and fungi that, through their interactions, have 
both positive and negative effects on each other and on their 
host [1]. In times of dysbiosis, polymicrobial infections can lead 
to aggressive forms of diseases that are usually difficult to treat. 
Co- colonization by Aspergillus fumigatus and Pseudomonas 
aeruginosa in the cystic fibrosis lung has poorer clinical outcomes 
compared to colonization by P. aeruginosa alone [2]. A large 
proportion of infections (30–60 %) caused by Candida albicans 
are polymicrobial and Staphylococcus aureus is one of the most 
common microbes isolated during these infections [3–5]. Infec-
tions caused by C. albicans affect large numbers of patients and 
a recent study found that in chemotherapy- immunosuppressed 
mice C. albicans can influence the resident bacterial commu-
nity and contribute to mucosal bacterial dysbiosis, facilitating 
enhanced invasion by Candida [6]. In recent years, advances in 
sequencing technologies have demonstrated that Candida rarely 
exists in isolation but rather as a heterogeneous biofilm with 
other fungal and bacterial species [7]. These types of infections 
in humans include catheter infections, burn wound infections, 
septicaemia, ventilator- associated pneumonia, keratitis, denture 
stomatitis, peritonitis, cystic fibrosis and urinary tract infections 
[1, 8]. The interactions between S. aureus and C. albicans are 
synergistic and result in increased mortality in animal models, 
which is associated with enhanced invasion, biofilm formation, 
exacerbated inflammatory responses and intrinsic resistance to 
antimicrobial chemotherapy [8–19]. Proteomic analysis of the 
interactions between S. aureus and C. albicans has demonstrated 
an increased abundance of proteins associated with stress and 
growth responses, and metabolism in the early stages of the 
interaction, although S. aureus had little effect on the proteome 
of C. albicans hyphae [20].
C. albicans virulence includes polymorphism and phenotypic 
switching, production of toxins (e.g. candidalysin), invasins 
(e.g. Als3p), biofilm formation and metabolic adaption 
[21, 22]. The virulence of S. aureus is multifaceted and allows 
the bacterium to interact with the host (fibronectin- binding 
proteins A and B), evade the immune response (chemotaxis 
inhibitory protein of staphylococci) and induce tissue damage 
(alpha toxin) [23–27]. During co- infection S. aureus can 
bind to Als3p in the C. albicans cell wall and this facilitates 
disseminated infection in an oral co- colonization model [8]. 
Interestingly, interactions between C. albicans and S. aureus 
in mixed species biofilm result in alterations in the proteome, 
resulting in increased abundance of proteins associated with 
resistance to oxidative stress and virulence [28]. To date, these 
pathogens have mostly been studied in isolation in higher 
vertebrates and there is a lack of a system that is compat-
ible with the 3R policies and enables the generation of rapid 
results and allows the screening of multiple interactions in a 
short space of time.
Larvae of the greater wax moth Galleria mellonella are a widely 
used model to study the virulence of microbial pathogens and 
to assess the efficacy of antimicrobial agents due to the many 
advantages associated with their use (e.g. ease of use, cost- 
effectiveness, lack of legal and ethical restrictions) [29–33]. 
More recently, larvae have been utilized to study the virulence 
of bacterial (e.g. S. aureus [34], Streptococcus pneumoniae [35] 
and Enterococcus faecalis [36, 37]) and fungal (e.g. C. albicans 
[38, 39], A. fumigatus [40] and Cryptococcus neoformans [41]) 
pathogens as well as their interactions with the cellular and 
humoral immune response of larvae. Larvae were also used to 
assess the interaction between S. aureus and C. albicans and 
show how co- infection reduced the efficacy of miconazole [14]. 
The aim of this work was to characterize the development of, 
and the host immune response to, mixed microbial co- infection 
in G. mellonella larvae in order to develop a simple but effective 
system to characterize polymicrobial infections in vivo.
METHodS
Strains and culture conditions
C. albicans MEN (a kind gift from Professor D. Kerridge, 
Cambridge, UK) was cultured in YEPD broth [2 % (w/v) 
glucose, 2 % (w/v) bactopeptone (Difco Laboratories), 1 % 
(w/v) yeast extract (Oxoid Ltd, Basingstoke, UK)]. S. aureus 
(clinical isolate) was cultured in nutrient broth (Oxoid). 
Cultures were grown overnight at 37 °C and 200 r.p.m. to the 
early stationary phase as described elsewhere [34]. Cells were 
harvested by centrifugation (2000 x g) and cell pellets were 
washed three times with phosphate- buffered saline (PBS) 
prior to injection into larvae. Stocks of C. albicans and S. 
aureus were maintained on YEPD agar plates as above but 
innate immune response of mammals to infection. The utility of G. mellonella larvae for studying polymicrobial infection is 
highlighted.
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supplemented with 2 % (w/v) agar] or nutrient agar plates, 
respectively.
Larval culture and inoculation
Sixth instar larvae of the greater wax moth G. mellonella 
(Livefoods Direct Ltd, UK) were stored in the dark at 15 °C 
and maintained in wood chippings [38]. Larvae weighing 
0.22±0.03 g were selected and used within 2 weeks of receipt. 
Ten healthy larvae per treatment and controls were placed in 
sterile 9 cm Petri dishes lined with Whatman filter paper and 
containing some wood shavings. Larvae were inoculated with 
S. aureus (enumerated using a spectrophotometer) through 
the last left pro- leg into the haemocoel with a Myjector 
U-100 insulin syringe (Terumo Europe NV, Belgium). For 
co- infection, larvae were administrated 20 µl of a solution 
containing C. albicans (enumerated using a haemocytometer) 
and S. aureus at the inoculum stated. Larvae were acclimatized 
to 37 °C for 1 h prior to all experiments and incubated at 37 °C 
for all studies. All experiments were performed independently 
on three separate occasions.
determination of proliferation of S. aureus in G. 
mellonella larvae
Larvae were infected with C. albicans or S aureus or co- infected 
with C. albicans and S aureus, and S. aureus proliferation larva−1 
was assessed over 48 h. Infected larvae (n=3) were homogenized 
using a pestle and mortar with 3 ml of PBS, serially diluted and 
plated onto nutrient agar (S. aureus) plates supplemented with 
0.1 g (v/v) amphotericin B and incubated at 37 °C for 24 h. The 
bacterial load was calculated as the S. aureus colony- forming 
units (c.f.u.) per larva and was based on the number of colonies 
that grew at specific dilutions. This protocol is described in detail 
elsewhere [34, 42].
Cryo-imaging of co-infected G. mellonella larvae
G. mellonella larvae were co- infected with C. albicans (1×105 
larva−1) and S. aureus (2×104 larva−1) and incubated at 37 °C 
for 0, 6, 24 and 48 h. Larvae (n=3) were embedded in Cryo- 
Imaging Embedding Compound (Bioinvision), flash- frozen 
in liquid nitrogen and mounted on a stage for sectioning 
[34, 40]. Sectioning and imaging was carried out every 10 µm 
using a Cryoviz (Bioinvision, Inc., Cleveland, OH, USA) cryo- 
imaging system.
determination of haemocyte density in G. mellonella 
larvae
Changes in haemocyte density was assessed by bleeding 40 µl 
of haemolymph from G. mellonella larvae (n=5) into a micro-
centrifuge tube on ice to prevent melanization. Haemolymph 
was diluted in 0.37 % (v/v) mercaptoethanol- supplemented 
Fig. 1. Survival of G. mellonella larvae following mono- and co- infection with C. albicans and S. aureus. Larvae were infected with 20 µl of 
C. albicans or S. aureus or co- infected (1×105 C. albicans with varying concentrations of S. aureus) and survival was assessed over 72 h at 
37 °C. Statistical significance was determined by comparing co- infected larvae to the relevant S. aureus mono- infected larvae (**, P<0.01; 
****, P<0.0001). Larvae were also injected with 20 µl PBS (PBS- injected). All values are the mean±se of three independent experiments.
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PBS and cell density was determined using a haemocytom-
eter. Haemocyte density was expressed as haemocyte density 
per larva. Experiments were performed on three independent 
occasions and the means±se were determined.
Quantitative proteomics of larval haemolymph
Quantitative proteomics was conducted on haemocyte- free 
haemolymph from larvae (n=10 with four biological repli-
cates) at 0, 6 and 24 h post- co- infection [C. albicans (1×105 
larva−1), S. aureus (2×104 larva−1)]. Protein (75 µg) was 
prepared according to established protocols [38]. Protein 
identification from the tandem mass spectrometry (MS/MS) 
data was performed using the Andromeda search engine in 
MaxQuant (version 1.2.2.5; http:// maxquant. org/) to correlate 
the data against a six- frame translation of the EST contigs for 
G. mellonella [43, 44] or the proteome for C. albicans or S. 
aureus (Uniprot).
Results processing, statistical analyses and graphics generation 
were conducted using Perseus v 1.5.5.3. Label- free quantifica-
tion (LFQ) intensities were log2- transformed and analysis of 
variance (ANOVA) of significance and t- tests between the 
haemolymph proteomes of 0, 6 and 24 h S. aureus- treated larvae 
were performed using a P- value of 0.05 and significance was 
determined using false discovery rate (FDR) correction (Benja-
mini–Hochberg). The (FDR was set at 1 % for both peptides 
and proteins. Proteins that had non- existent values (indicative 
of absence or very low abundance in a sample) were also used 
in statistical analysis of the total differentially expressed group 
following imputation of the zero values using a number close 
to the lowest value of the range of proteins plus or minus the 
standard deviation. After data imputation these proteins were 
included in subsequent statistical analysis.
Statistical analysis
All experiments were performed on three independent occa-
sions and the results are expressed as the mean±se. All of 
the statistical analysis listed was performed using GraphPad 
Prism v 6.00 (one- way ANOVA; survival, haemocyte density, 
c.f.u.). Differences were considered significant at P<0.05.
data availability
The mass spectrometry (MS) proteomics data and MaxQuant 
search output files have been deposited to the ProteomeX-
change Consortium [45] via the PRIDE partner repository 
with the dataset identifier PXD014273.
RESuLTS
Response of G. mellonella larvae to co-infection by 
C. albicans and S. aureus
Infection of larvae with an inoculum of 1×105 C. albicans 
larva−1 resulted in no significant decrease in survival over 
72 h as compared to non- infected controls. Infection of larvae 
with S. aureus (2×106 larva−1) resulted in larval survival of 
80±10 % at 24 h, 55.93±9.62 % at 48 h and 10±5.15 % at 72 h 
post- infection (Fig. 1). Co- infection of larvae with C. albicans 
(1×105 larva−1) and S. aureus (2×104 larva−1) resulted in a 
significant decrease in survival [24 h, 70±3.33 % (P<0.01); 48 h, 
10±3.33 % (P<0.0001); 72 h, 5±6.66 % (P<0.0001)] compared 
to larvae that received S. aureus (2×104 larva−1) alone at 24, 
48 (100±0 %) and 72 h (96.66±5.77 %). Co- infection of G. 
mellonella larvae with C. albicans (1×105 larva−1) and S. aureus 
(2×106 larva−1) reduced survival to 30±6.66 % (P<0.0001) at 
24 h and 0±0 % (P<0.0001) at 48 and 72 h post- infection, rela-
tive to mono- infection with S. aureus (2×106 larva−1) (Fig. 1).
dissemination of infection throughout the host
The microbial burden of co- infected larvae was assessed by 
measuring S. aureus c.f.u larva−1 in co- infected [C. albicans 
(1×105 larva−1) with S. aureus (2×104 or 2×106 larva−1)] larvae 
and comparing these to larvae infected solely with S. aureus 
(2×104 or 2×106 larva−1). Co- infected larvae displayed a signif-
icantly higher S. aureus c.f.u larva−1 at 6 (1.51±0.17×105 c.f.u. 
larva−1, P<0.05), 24 (1.01±0.38×107 c.f.u. larva−1, P<0.05) 
and 48 h (2.01±0.23×108 c.f.u larva−1, P<0.001) compared 
to larvae infected with S. aureus (2×104 larva−1) alone at 6 
(4.49±0.5×104 c.f.u larva−1), 24 (4.51±0.37×105 c.f.u larva−1) 
and 48 h (1.05±0.33×107 c.f.u larva−1). There was a significant 
increase in S. aureus c.f.u. at 6 (1.55±0.59×106 c.f.u larva−1, 
P<0.001), 24 (2.58±0.52×108 c.f.u larva−1, P<0.05) and 48 h 
(6.12±0.73×108, P<0.01) post- infection in co- infected larvae 
compared to those infected solely with S. aureus (2×106 larva−1) 
at 6 (9.96±0.68×105 c.f.u. larva−1), 24 (9.41±0.34×107 c.f.u. 
larva−1) and 48 h (3.21±0.51×108 c.f.u. larva−1) (Fig. 2).
Previous work has visualized the dissemination of C. albicans 
and S. aureus, separately, in larvae [39]. In this case cryo- 
imaging was employed to assess the development of dual 
infection within G. mellonella larvae. Larvae were co- infected 
with C. albicans (1×105 larva−1) and S. aureus (2×104 larva−1) 
and cryo- imaging was performed at 0, 6, 24 and 48 h post- 
infection (Fig. 3). Six hours post- infection melanized nodules 
(black arrows) appeared around the site of inoculation (white 
arrows) and throughout the host. By 24 h post- infection there 
was extensive melanization (red arrow) of larval tissue, espe-
cially around the site of inoculation and nodules were visible 
throughout the larva. By 48 h post- infection the survival rate 
for G. mellonella larvae was 10±3.33% and there was extensive 
melanization throughout the larvae as well as a large number 
of distinct nodules.
Analysis of larval immune response to C. albicans 
and S. aureus dual infection
Alterations in circulating haemocyte density in co- infected 
larvae were determined in order to assess the cellular response 
to co- infection. Uninfected larvae had a haemocyte density of 
2.4±0.17×105 haemocytes larva−1. Mono- infection with C. albi-
cans (1×105 larva−1) resulted in a small alteration in haemocyte 
density at 24 [2.18±0.22×105 haemocytes larva−1 (60 μl haemo-
lymph)] and 48 h (2.09±0.13×105). Inoculation of larvae with 
S. aureus (2×104 larva−1) also resulted in a change in haemocyte 
density at 6 (1.26±0.36×105), 24 (1.30±0.73×105) and 48 h 
(1.42±0.13×105) post- infection. Mono- infection with S. aureus 
2×106 larva−1 produced alterations in circulating haemocyte 
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density at 6 (5.70±0.25×105, P<0.0001) and 24 h (6.55±0.27×105, 
P<0.01) post- infection (Fig. 4).
Co- infection of larvae with C. albicans (1×105 larva−1) and S. 
aureus (2×104 larva−1) resulted in an increase in the density 
of circulating haemocytes at 6 (1.69±0.13×105, P<0.05), 
24 (3.63±0.14×105, P<0.0001) and 48 h (5.11±0.20×105, 
P<0.05) post- infection compared to larvae infected solely 
with S. aureus (2×104 larva−1). Co- infection of C. albicans 
(1×105 larva−1) with S. aureus at an inoculum of 2×106 larva−1 
(3.19±0.31×105, P<0001) resulted in a significant decrease 
in circulating haemocyte density relative to larvae infected 
solely with S. aureus (2×106 larva−1) 6 h post- infection (2×105, 
3.15±0.17×105; 2×106, 5.70±0.25×105).
Quantitative proteomic analysis was performed on the 
cell- free haemolymph of G. mellonella larvae following 
co- infection with C. albicans (1×105 larva−1) and S. aureus 
(2×104 larva−1) for 0, 6 and 24 h post- infection. In total, 2293 
peptides were identified, representing 351 proteins with 
2 or more peptides and 48 and 83 (6 vs 0 h and 24 vs 0 h, 
respectively) proteins were determined to be differentially 
abundant (ANOVA, P<0.05) with a fold change of >1.5. A 
total of 34, 46 and 84 proteins at 0, 6 and 24 h, respectively, 
were deemed exclusive (Fig. S1, available in the online version 
of this article). These proteins were subsequently used to 
statistically analyse the total differentially expressed group 
after imputation of the zero values as described and were then 
included in statistical analysis after data imputation. A prin-
cipal component analysis (PCA) was performed on all filtered 
proteins and distinguished the 0, 6 and 24 h C. albicans- and 
S. aureus- treated samples. A clear difference between the 0, 6 
and 24 h proteome was observed (Fig. S2).
The proteins that showed increased relative abundance in the 
larvae co- infected for 6 h compared to the control were gusta-
tory receptor candidate 25 (+10.5- fold), gloverin- like protein 
(+7.9- fold), putative defence protein Hdd11 (+7.1- fold), actin 
3 (+6.6- fold) and paramyosin (+5- fold). The proteins that 
showed decreased relative abundance in the larvae co- infected 
for 6 h compared to the control were cathepsin B- like cysteine 
proteinase (−4.9- fold), apolipophorins (−2.4- fold), beta-1, 
3- glucan- binding protein (−2.3- fold) and methionine- rich 
storage protein (−2.2- fold) (Fig. 5a, Table S1).
The proteins that showed increased relative abundance in 
co- infected larvae at 24 h compared to the control larvae 
were cecropin- A (+45.4- fold), gustatory receptor candidate 
25 (+41.7- fold), cecropin- d- like peptide (+37.8- fold), puta-
tive defence protein Hdd11 (+33.3- fold), gloverin (+19.3- 
fold) peptidoglycan- recognition protein- LB (+14.0- fold), 
serpin- 4B (+12.9- fold) and salivary cysteine- rich peptide 
precursor (+12.6- fold). The proteins that showed decreased 
relative abundance in larvae co- infected for 24 h compared 
Fig. 2. S. aureus c.f.u. larva−1 obtained from G. mellonella larvae infected with S. aureus cells (2×106 and 2×106 larva−1) or co- infected 
larvae over 48 h at 37 °C. Co- infection with C. albicans and S. aureus (C. a+S. a) results in an increase in bacterial load in larvae from 6 
to 48 h as determined by plating on nutrient agar plates. Statistical analysis was carried out by comparing co- infected larvae (C. a+S. 
a) to larvae infected solely with S. aureus (S. a) at their respective timepoints, (*, P<0.05; **, P<0.01). All values are the mean±se of three 
independent experiments.
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to the control larvae were apolipophorins (−62.4- fold), 
alpha- esterase 45 (−7.7- fold), serine proteinase (−6.2- fold), 
saposin- related precursor (−5.8- fold), carboxylesterase 
CarE-11 precursor (−5.6- fold) and cathepsin B- like cysteine 
proteinase (−4- fold) (Fig. 5b, Table S2). A range of antimi-
crobial peptides and proteins (Fig. S3a), proteins associated 
with bacterial and fungal recognition, and proteins involved 
in nodule formation (Fig. S3b) were identified within the 
co- infected larval haemolymph.
A range of C. albicans and S. aureus proteins were also detected 
in co- infected G. mellonella larval haemolymph. A total of 23 
C. albicans proteins were identified in co- infected G. mellonella 
larval haemolymph and included Hsp70 family ATPase, heat 
shock protein SSA2 and peroxiredoxin TSA1- A (Table S3). In 
addition, 20 S. aureus proteins such as staphopain B and HTH- 
type transcriptional regulator SarR were detected in haemo-
lymph 24 h post- infection (Table S4).
dISCuSSIon
The incidence of polymicrobial infection is possibly underes-
timated as current routine clinical microbiological investiga-
tion could never encompass the vast number and diversity of 
microbes present within the human micro- and mycobiome. 
Advances in technologies associated with the detection of these 
microbes will eventually enter the clinic and this will require 
the reclassification of many mono- infections as polymicrobial 
infections. The work presented here aimed to develop an in 
vivo system to study the pathogenesis of polymicrobial infec-
tion using G. mellonella larvae, which have been widely used for 
studying the development of single- species infections [46–49].
Inoculation of larvae with C. albicans (1×105 larva−1) or S. 
aureus (2×104 larva−1) resulted in no reduction in survival, 
but co- inoculation of larvae with these doses resulted in a 
large decrease in survival. This suggests that the interactions 
Fig. 3. CryoViz- imaging of G. mellonella larvae co- infected with C. albicans and S. aureus. Larvae (n=3) were co- infected with C. albicans 
(1×105 larva−1) and S. aureus (2×104 larva−1) for 0, 6, 24 and 48 h at 37 °C. Larvae were embedded, sectioned (10 µm) and visualized using 
a Cryoviz (Bioinvision, Inc., Cleveland, OH, USA) cryo- imaging system. Point of inoculation, white arrows; nodules, black arrows; extensive 
melanization, red arrows.
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between C. albicans and S. aureus may be synergistic, 
which has previously been documented in murine studies 
[1, 8, 9, 13, 14, 16, 50]. Infection of G. mellonella larvae 
with S. aureus (2×106 larva−1) or C. albicans (5×105 larva−1) 
in mono- infection resulted in 70 and 44 % larval mortality 
after 48 h, respectively [34, 38]. Co- infection of larvae with 
S. aureus (1×105 larva−1) and C. albicans (2×104 larva−1) 
produced mortality of 90 %, 48 h post- infection. Interestingly, 
Fig. 4. Alteration in circulating haemocyte density following inoculation with S. aureus cells alone and in combination with C. albicans. 
G. mellonella larvae were inoculated with 20 µl S. aureus cells (2×104 and 2×106 larva−1) alone or in combination with C. albicans (1×105 
larva−1) and haemocytes were extracted and enumerated from 6, 24 and 48 h post- inoculation at 37 °C. Statistical analysis was performed 
by comparing co- infected larvae (C. a+S.a) to S. aureus- only- treated larvae at their at respective doses and time points (*, P<0.05; **, 
P<0.01; ***, P<0.001; ****, P<0.0001). All values are the mean±se of three independent experiments.
Fig. 5. Proteomic responses of G. mellonella larval haemolymph following co- infection by C. albicans (1×105 larva−1) and S. aureus 
(2×104 larva−1) after 6 (a) and 24 (b) h at 37 °C. Volcano plots represent protein intensity difference (log
2
 mean intensity difference) and 
significance in differences (- log P- value) based on a two- sided t-test. Proteins above the line are considered statistically significant (P 
value<0.05) and those to the right and left of the vertical lines indicate relative fold changes>1.5. Annotations are given for the most 
differentially abundant proteins identified in haemolymph from co- infected larvae 6 and 24 h. These plots are based upon post imputed 
data.
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single doses of C. albicans and S. aureus were non- lethal 5 days 
post- infection in mice but when combined resulted in 70 % 
mortality 2 days post- infection [50].
Co- inoculation of larvae resulted in a significant increase in S. 
aureus c.f.u larva−1 relative to mono- infection. In co- infected 
mice, the microbial burden was significantly higher in the 
kidney and spleen compared to mono- infection [50]. Interest-
ingly, the total bacterial c.f.u. in co- infected larvae, regardless 
of dose, was 10.65±4.40- fold higher than in S. aureus- only- 
infected larvae.
Cryo- imaging was utilized to assess the dissemination of 
co- infection throughout the host over 48 h. By 24 h there 
was significant nodule formation and by 48 h there was 
extensive melanization and widespread nodule formation. 
Melanization of co- infected larvae is more systemic than 
that observed in mono- infection, which appears as local-
ized nodules throughout the host [34, 39]. Previous results 
indicated that infection of larvae with a higher inoculum 
of C. albicans (5×105 larva−1) or S. aureus (2×106 larva−1) in 
mono- infection resulted in more cuticular melanization and 
larger granuloma (nodule)- type structure formation [34, 39]. 
This may indicate that co- infection, at a lower cell density, 
which ultimately produced a larger decrease in survival 
relative to mono- infection, may have activated a less robust 
immune response to co- infection (summarized in Table 1) 
and via less cuticular melanization. This aberrant immune 
response (e.g. decreased AMP abundance in co- infection 
relative to mono- infection) could be due to the acute and 
accelerated proliferation of S. aureus in the presence of C. 
albicans, which results in an uncontrollable bacterial burden 
that cannot be cleared in time by the host. Peters and Noverr 
[50] demonstrated that co- infection was associated with an 
increased inflammatory response characterized by an up to 
100- fold increase in inflammatory cytokines (e.g. IL-6) and 
neutrophil influx [50].
Infection of larvae with a low inoculum of S. aureus (2×104 
larva−1) with C. albicans (1×105 larva−1) resulted in a signifi-
cant increase in haemocyte density, however an inoculum 
of S. aureus (2×106 larva−1) with C. albicans (1×105 larva−1) 
produced a decrease in haemocyte density compared to S. 
aureus mono- infection. The increase in haemocyte density is 
probably a result of the release of haemocytes usually attached 
to the linings of internal surface of the cuticle and organs 
such as the fat body [51], while the decrease in haemocyte 
density associated with the higher inoculum may be due to 
the aggregation of haemocytes at the site of inoculation in 
order to halt the spread of the infection.
The humoral immune response of larvae to co- infection 
was determined by label- free MS. At 6 h post co- infection 
antimicrobial peptide gloverin- like protein had increased 7.9- 
fold. Gloverins are heat- stable antibacterial polypeptides that 
bind to bacterial lipopolysaccharide and components of the 
fungal cell wall. It was previously demonstrated that Escheri-
chia coli and S. aureus induce gloverin expression in Bombyx 
mori and Manduca sexta [52, 53]. Gloverins display activity 
against yeasts but do not possess anti-S. aureus activity [53]. 
In C. albicans- infected G. mellonella larvae, gloverin was 
not detected 6 h post- infection but had increased 52- fold 
at 24 h post- infection, however in S. aureus- infected larvae 
gloverin had increased 20- fold at 6 h and 121- fold at 24 h 
post- infection [34, 38]. Similarly, PGRP- B increased 3- fold in 
co- infected larvae but 2.3- fold in C. albicans and 6- fold in S. 
aureus mono- infected larvae [34, 38]. These experiments were 
performed with five times more C. albicans (5×105 larva−1) 
Table 1. Comparison of the different proteomic responses between single infection of G. mellonella larvae with C. albicans [30], S. aureus [29] and co- 
infection (current study). Fold change is 24 h infected larval haemolymph relative to 0 h relevant infected control*
Infection and reference C. albicans [30] S. aureus [29] Co- infection (C. albicans and S. 
aureus)
Inoculum size 5×105 20 µl−1 2×106 20 µl−1 1×105 (C. albicans) and 2×106 (S. 
aureus) 20 µl−1
Protein name Fold change (+/−)* Fold change (+/−)* Fold change (+/−)*
Invasion Muscle protein 20- like protein +173.3- fold nd +8.6- fold
Nodulation Hdd11 +49.4- fold +7.24- fold +33.3- fold
Antimicrobial peptide Gloverin +52.5- fold +121.69- fold +19.3- fold
Cecropin- D +22.8- fold +73.7- fold +37.8- fold
Detoxification Glutathione s transferase +114.1- fold nd nd
Thioredoxin +3.2- fold −3.94- fold nd
Microbial recognition PG- RP LB +71.6- fold +9.53- fold +14- fold
PG- RP B +7.5- fold +17.35- fold nd
β-glucan RP −28.6- fold +2.16- fold nd
nd, non detected; PG RP, peptidoglycan recognition protein.
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and 100 times more S. aureus (2×106 larva−1) compared to 
co- infected larvae [C. albicans (1×105 larva−1), S. aureus 
(2×104 larva−1)] in the current study (Table 1). Members of 
the phenoloxidase cascade (e.g. prophenoloxidase activating 
factor 3) increased in abundance by 4.2- fold in co- infected 
larvae 6 h post- co- infection but had only increased 2.4- fold 
in C. albicans and 2.85- fold in S. aureus at 6 h post- mono- 
infection (Table 1). The phenoloxidase cascade is a series of 
enzymatic reactions that result in the formation of phenoloxi-
dase, which participates in melanotic encapsulation, wound 
healing and cuticle sclerotization, and this reaction is analo-
gous to the mammalian complement cascade in terms of 
protein structure and function [54].
By 24 h post- co- infection, the abundance of cecropin A had 
increased 45- fold as compared to control larvae. Cecropin A 
is a 37 amino acid antimicrobial peptide first isolated from 
Hyalophora cecropia. It demonstrates antibacterial activity 
against multidrug- resistant bacteria (e.g. S. aureus), induces 
C. albicans apoptosis and has immune- modulatory effects 
on macrophages [55–57]. Cecropin A had increased in C. 
albicans mono- infected larvae (4.5- fold) at 6 h post- infection, 
but increased 10.5- fold 24 h post-S. aureus infection [34, 38]. 
Moricin- like peptide increased 21- and 20.8- fold during C. 
albicans and S. aureus mono- infection, respectively, but was 
not detected in co- infected larvae. Moricins are secreted 
pro- peptides that are activated via proteolysis and increase 
the permeability of bacterial and fungal membranes. G. 
mellonella moricins are highly active against yeasts and S. 
aureus [58, 59]. Hdd11 had increased by 7.1- and 33.33- fold at 
6 and 24 h post- co- infection. However, Hdd11, which shares 
homology with noduler from the tasar silkworm (Antheraea 
mylitta) [60, 61], had increased by 49- fold and 7.24- fold at 
24 h post- C. albicans and S. aureus infection, respectively. 
Noduler shares a reeler domain with Hdd11 and binds insect 
haemocytes, bacterial LPS and fungal beta glucan, is enriched 
within nodules (G. mellonella nodules are highly enriched 
for Hdd11 protein; unpublished observation) and is impor-
tant during the nodulation response [62]. Apolipophorin 
decreased 1.9- fold in abundance in C. albicans mono- infected 
larvae and was not detected during S. aureus infection, but 
was found to be significantly decreased (64.2- fold) during 
co- infection by S. aureus and C. albicans. Apolipophorin plays 
a role in lipid transport [63, 64] but has immune- modulatory 
activity and augments the activity of lysozyme [65], poten-
tiates the activity of antimicrobial peptides [66], regulates 
phenoloxidase activity [67, 68] and is a pathogen recognition 
receptor and opsonin of lipopolysaccharide, lipoteichoic acids 
and fungal β-glucan [69]. Furthermore, lysozyme decreased 
(4.9- fold) during C. albicans mono- infection of larvae and 
increased (31.38- fold) during S. aureus mono- infection, but 
was not detected in co- infected larvae.
It is possible that co- infection with C. albicans and S. aureus 
activates a less robust immune response in terms of recogni-
tion and opsonin proteins (PGRPs), which are essential for 
early microbial recognition to prevent the spread of infec-
tion. Interestingly, the fungicidal AMP gloverin decreased 
in abundance during co- infection relative to mono- infection 
by both organisms, which may indicate a defective killing 
response of larvae to C. albicans, which, in turn, may allow 
increased proliferation of S. aureus due to increased survival 
of C. albicans.
In total, 23 C. albicans and 20 S. aureus proteins were found in 
haemolymph during co- infection of G. mellonella larvae. C. 
albicans heat shock protein SSA2 and peroxiredoxin TSA1- A 
and S. aureus staphopain B were found in haemolymph 24 h 
post- infection. SSA1 can induce host cell endocytosis of C. 
albicans, which leads to increased virulence [70] and plays 
a role in resistance to antimicrobial peptides and antifungal 
agents [71–73]. Peroxiredoxin TSA1- A was also detected 
in larvae mono- infected with C. albicans [39] and plays a 
role in cell protection against oxidative stress [74]. S. aureus 
staphopain B decreased the phagocytic activity of neutro-
phils and cleaved CD31, resulting in increased clearance by 
macrophages [75]. It is possible that these proteins display 
activity against insect haemocytes and antimicrobial peptides 
or play a role in detoxification of the microbial cell from the 
host immune response.
Co- infection with C. albicans and S. aureus produced elevated 
mortality relative to mono- infection and this is associated 
with increased S. aureus proliferation, alterations in circu-
lating haemocyte densities and systemic dissemination 
of infection throughout larvae. The immune proteome of 
co- infected larvae displays an altered immune response rela-
tive to infection by C. albicans [38] or S. aureus [34] at a higher 
inoculum. This study demonstrates that the G. mellonella 
larvae may be a useful in vivo system to study co- infection by 
dual- species, inter- kingdom microbial pathogens. This model 
could be adapted for other common interactions (antagonistic 
or synergistic) that exist during human infection. This is 
particularly important as advances in healthcare that ulti-
mately result in inhibition of the host immune response (e.g. 
SYK inhibitors) will facilitate the emergence of new pathogens 
and co- infection by diverse pathogens that are well adapted 
to thrive in the immunocompromised host.
Funding information
G. S. is the recipient of a Maynooth University doctoral studentship. The 
Q- exactive mass spectrometer was funded under the SFI Research 
Infrastructure Call 2012, grant number 12/RI/2346 (3). This publication 
emanated from research supported in part by a research grant from 
Science Foundation Ireland (SFI) and is co- funded under the European 
Regional Development Fund under grant number 12/RC/2275_P2.
Acknowledgements
The assistance of Dr Ilona Dix with Cryoviz imaging is acknowledged.
Author contributions
G. S. and K. K. designed the experiments. G. S. and L. S. performed the 
experiments and analysed the results. G. S. and K. K. wrote the manu-
script. All authors have read and approved the manuscript.
Conflicts of interest
The authors declare that there are no conflicts of interest.
references
 1.  shirtliff ME, Peters BM, Jabra- rizk MA. Cross- kingdom inter-
actions: Candida albicans and bacteria. FEMS Microbiol Lett 
2009;299:1–8.
384
Sheehan et al., Microbiology 2020;166:375–385
 2.  reece E, segurado r, Jackson A, Mcclean s, renwick J et  al. 
Co- colonisation with Aspergillus fumigatus and Pseudomonas 
aeruginosa is associated with poorer health in cystic fibrosis 
patients : an Irish registry analysis. BMC Pulm Med 2017:1–8.
 3.  Klotz sA, Chasin Bs, Powell B, Gaur NK, Lipke PN. Polymicro-
bial bloodstream infections involving Candida species: analysis 
of patients and review of the literature. Diagn Microbiol Infect Dis 
2007;59:401–406.
 4.  reno J, doshi s, tunali AK, stein B, Farley MM et al. Epidemiology 
of methicillin- resistant Staphylococcus aureus bloodstream coin-
fection among adults with candidemia in atlanta, GA, 2008–2012. 
Infect Control Hosp Epidemiol 2015;36:1298–1304.
 5.  o'donnell LE, Millhouse E, sherry L, Kean r, Malcolm J et  al. 
Polymicrobial Candida biofilms: friends and foe in the oral cavity. 
FEMS Yeast Res 2015;15:fov077.
 6.  Bertolini M, ranjan A, thompson A, diaz Pi, sobue t et al. Candida 
albicans induces mucosal bacterial dysbiosis that promotes inva-
sive infection. PLoS Pathog 2019;15:e1007717.
 7.  diaz Pi, strausbaugh Ld, dongari- Bagtzoglou A. Fungal- bacterial 
interactions and their relevance to oral health: linking the clinic 
and the bench. Front Cell Infect Microbiol 2014;29:101.
 8.  schlecht LM, Peters BM, Krom BP, Freiberg JA, 
hänsch GM et al. Systemic Staphylococcus aureus infection medi-
ated by Candida albicans hyphal invasion of mucosal tissue. Micro-
biology 2015;161:168–181.
 9.  Kong EF, tsui C, Kucharíková s, Van dijck P, Jabra- rizk MA. Modu-
lation of Staphylococcus aureus response to antimicrobials by the 
Candida albicans quorum sensing molecule farnesol. Antimicrob 
Agents Chemother 2017;61.
 10.  Allison dL, scheres N, Willems hME, Bode Cs, Krom BP et al. The 
host immune system facilitates disseminated Staphylococcus 
aureus disease due to phagocytic attraction to Candida albicans 
during coinfection: a case of bait and switch. Infect Immun 2019;87.
 11.  todd oA, Peters BM. Candida albicans and Staphylococcus aureus 
pathogenicity and polymicrobial interactions: lessons beyond 
koch’s postulates. Journal of Fungi 2019;5:81.
 12.  Kong EF, tsui C, Kucharíková s, Andes d, Van dijck P et  al. 
Commensal Protection of Staphylococcus aureus against Antimi-
crobials by Candida albicans Biofilm Matrix. MBio 2016;7.
 13. harriott MM, Noverr MC. Candida albicans and Staphylococcus 
aureus form polymicrobial biofilms: effects on antimicrobial resist-
ance. Antimicrob Agents Chemother 2009;53:3914–3922.
 14. Kean r, rajendran r, haggarty J, townsend EM, short B et  al. 
Candida albicans mycofilms support Staphylococcus aureus coloni-
zation and enhances miconazole resistance in dual- species inter-
actions. Front Microbiol 2017;8.
 15.  de Carvalho dias K, Barbugli PA, de Patto F, Lordello VB, de Aquino 
Penteado L et al. Soluble factors from biofilm of Candida albicans 
and Staphylococcus aureus promote cell death and inflammatory 
response. BMC Microbiol 2017;17.
 16.  Krüger W, Vielreicher s, Kapitan M, Jacobsen id, Niemiec MJ. 
Fungal- Bacterial interactions in health and disease. Pathogens 
2019;8:70.
 17.  todd oA, Fidel PL, harro JM, hilliard JJ, tkaczyk C et al. Candida 
albicans augments Staphylococcus aureus virulence by engaging 
the Staphylococcal agr quorum sensing system. MBio 2019;10.
 18.  Carolus h, Van dyck K, Van dijck P, albicans C. Candida albicans 
and Staphylococcus species: a threatening Twosome. Front Micro-
biol 2019;10.
 19.  ikeh MAC, Fidel PL, Noverr MC. Identification of specific compo-
nents of the eicosanoid biosynthetic and signaling pathway 
involved in pathological inflammation during intra- abdominal 
infection with Candida albicans and Staphylococcus aureus. Infect 
Immun 2018;86.
 20.  Peters BM, Jabra- rizk MA, scheper MA, Leid JG, Costerton JW 
et al. Microbial interactions and differential protein expression in 
Staphylococcus aureus–Candida albicans dual- species biofilms. 
FEMS Immunol Med Microbiol 2010;59:493–503.
 21.  Kasper L, König A, Koenig P- A, Gresnigt Ms, Westman J et al. The 
fungal peptide toxin Candidalysin activates the NLRP3 inflam-
masome and causes cytolysis in mononuclear phagocytes. Nat 
Commun 2018;9.
 22.  Mayer FL, Wilson d, hube B. Candida albicans pathogenicity mech-
anisms. Virulence 2013;4:119–128.
 23. Lacey K, Geoghegan J, McLoughlin r. The role of Staphylococcus 
aureus virulence factors in skin infection and their potential as 
vaccine antigens. Pathogens 2016;5:22.
 24.  shinji h, Yosizawa Y, tajima A, iwase t, sugimoto s et  al. Role 
of Fibronectin- Binding Proteins A and B in In Vitro Cellular Infec-
tions and In Vivo Septic Infections by Staphylococcus aureus. Infect 
Immun 2011;79:2215–2223.
 25.  Bhakdi s, tranum- Jensen J. Alpha- Toxin of Staphylococcus aureus. 
Microbiol Rev 1991;55:733–751.
 26.  Burman Jd, Leung E, Atkins KL, o’seaghdha MN, Lango L et  al. 
Interaction of human complement with Sbi, a staphylococcal 
immunoglobulin- binding protein: indications of a novel mecha-
nism of complement evasion by Staphylococcus aureus. J Biol 
Chem 2008;283:17579–17593.
 27.  Jongerius i, Köhl Jörg, Pandey MK, ruyken M, van Kessel KPM 
et al. Staphylococcal complement evasion by various convertase- 
blocking molecules. J Exp Med 2007;204:2461–2471.
 28.  Jardeleza C, Jones d, Baker L, Miljkovic d, Boase s et  al. Gene 
expression differences in nitric oxide and reactive oxygen species 
regulation point to an altered innate immune response in chronic 
rhinosinusitis. Int Forum Allergy Rhinol 2013;3:193–198.
 29.  tsai CJ- Y, Loh JMs, Proft t, Jia C, - Yun t, Mei J, Loh s. Galleria 
mellonella infection models for the study of bacterial diseases and 
for antimicrobial drug testing. Virulence 2016;7:214–229.
 30.  senior NJ, Bagnall MC, Champion oL, reynolds sE, La ragione rM 
et al. Galleria mellonella as an infection model for Campylobacter 
jejuni virulence. J Med Microbiol 2011;60:661–669.
 31.  Borman AM, szekely A, Johnson EM. Comparative Pathogenicity 
of United Kingdom Isolates of the Emerging Pathogen Candida 
auris and Other Key Pathogenic Candida Species. mSphere 
2016;1:e00189–16.
 32.  Kavanagh K, sheehan G. The use of Galleria mellonella larvae 
to identify novel antimicrobial agents against fungal species of 
medical interest. JoF 2018;4:113.
 33.  Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and 
non- vertebrate animal model systems to study the virulence of 
human pathogenic fungi. PLoS Pathog 2007;3:e101.
 34.  sheehan G, dixon A, Kavanagh K. Utilization of Galleria mellonella 
larvae to characterize the development of Staphylococcus aureus 
infection. Microbiology 2019;165:863–875.
 35.  Evans BA, rozen dE. A Streptococcus pneumoniae infection model 
in larvae of the wax moth Galleria mellonella. Eur J Clin Microbiol 
Infect Dis 2012;31:2653–2660.
 36.  La rosa sL, Casey PG, hill C, diep dB, Nes iF et al. In Vivo assess-
ment of growth and virulence gene expression during commensal 
and pathogenic lifestyles of luxABCDE -Tagged Enterococcus 
faecalis strains in murine gastrointestinal and intravenous infec-
tion models. Appl Environ Microbiol 2013;79:3986–3997.
 37.  Leanti La rosa s, diep dB, Nes iF, Brede dA. Construction and 
Application of a luxABCDE reporter system for real- time moni-
toring of enterococcus faecalis gene expression and growth. Appl 
Environ Microbiol 2012;78:7003–7011.
 38.  sheehan G, Kavanagh K. Analysis of the early cellular and humoral 
responses of Galleria mellonella larvae to infection by Candida albi-
cans. Virulence 2018;9:163–172.
 39.  sheehan G, Kavanagh K. Proteomic analysis of the responses of 
Candida albicans during infection of Galleria mellonella larvae. JoF 
2019;5:7.
 40.  sheehan G, Clarke G, Kavanagh K. Characterisation of the cellular 
and proteomic response of Galleria mellonella larvae to the devel-
opment of invasive aspergillosis. BMC Microbiol 2018;18.
385
Sheehan et al., Microbiology 2020;166:375–385
 41.  London r, orozco Bs, Mylonakis E. The pursuit of cryptococcal 
pathogenesis: heterologous hosts and the study of cryptococcal 
hostâ€“pathogen interactions. FEMS Yeast Res 2006;6:567–573.
 42.  silva LN, da hora GCA, soares tA, Bojer Ms, ingmer h et al. Myri-
cetin protects Galleria mellonella against Staphylococcus aureus 
infection and inhibits multiple virulence factors. Sci Rep 2017;7.
 43.  Cox Jürgen, Neuhauser N, Michalski A, scheltema rA, 
olsen JV et al. Andromeda: a peptide search engine integrated into 
the MaxQuant environment. J Proteome Res 2011;10:1794–1805.
 44.  Vogel h, Altincicek B, Glöckner G, Vilcinskas A. A comprehensive 
transcriptome and immune- gene repertoire of the lepidopteran 
model host Galleria mellonella. BMC Genomics 2011;12:308.
 45.  Côté rG, Griss J, dianes JA, Wang r, Wright JC et  al. The prot-
eomics identification (pride) converter 2 framework: an improved 
suite of tools to facilitate data submission to the pride data-
base and the ProteomeXchange Consortium. Mol Cell Proteomics 
2012;11:1682–1689.
 46.  Maguire r, Kunc M, hyrsl P, Kavanagh K. Caffeine administra-
tion alters the behaviour and development of Galleria mellonella 
larvae. Neurotoxicol Teratol 2017;64:37–44.
 47.  Gu W, Yu Q, Yu C, sun s. In vivo activity of fluconazole/tetracycline 
combinations in Galleria mellonella with resistant Candida albicans 
infection. J Glob Antimicrob Resist 2018;13:74–80.
 48.  Mylonakis E, Moreno r, El Khoury JB, idnurm A, heitman J et al. 
Galleria mellonella as a model system to study Cryptococcus 
neoformans pathogenesis. Infect Immun 2005;73:3842–3850.
 49.  Lim W, Melse Y, Konings M, Phat duong h, Eadie K et al. Addressing 
the most neglected diseases through an open research model: the 
discovery of fenarimols as novel drug candidates for eumycetoma. 
PLoS Negl Trop Dis 2018;12:e0006437.
 50.  Peters BM, Noverr MC. Candida albicans- staphylococcus aureus 
polymicrobial peritonitis modulates host innate immunity. Infect 
Immun 2013;81:2178–2189.
 51.  ratcliffe NA. Invertebrate immunity — a primer for the non- 
specialist. Immunol Lett 1985;10:253–270.
 52.  Yi hY, deng XJ, Yang WY, Zhou CZ, Cao Y et al. Gloverins of the silk-
worm Bombyx mori: structural and binding properties and activi-
ties. Insect Biochem Mol Biol 2013;43:612–625.
 53.  XX X, Zhong X, hY Y, XQ Y. Manduca sexta gloverin binds microbial 
components and is active against bacteria and fungi. Dev Comp 
Immunol 2012;38:275–284.
 54.  sheehan G, Garvey A, Croke M, Kavanagh K. Innate humoral 
immune defences in mammals and insects: The same, with differ-
ences ? Virulence 2018;9:1625–1639.
 55.  Yun J, Lee dG. Cecropin A- induced apoptosis is regulated by ion 
balance and glutathione antioxidant system in Candida albicans. 
IUBMB Life 2016;68:652–662.
 56.  Lee E, shin A, Kim Y. Anti- Inflammatory activities of cecropin 
A and its mechanism of action. Arch Insect Biochem Physiol 
2015;88:31–44.
 57.  Lee E, Jeong K- W, Lee J, shin A, Kim J- K et al. Structure- Activity 
relationships of cecropin- like peptides and their interactions with 
phospholipid membrane. BMB Rep 2013;46:282–287.
 58.  hara s, Moricin YM. A novel type of antibacterial peptide 
isolated from the silkworm, Bombyx mori. J Biol Chem 
1995;270:29923–29927.
 59.  Brown sE, howard A, Kasprzak AB, Gordon Kh, East Pd. The 
discovery and analysis of a diverged family of novel antifungal 
moricin- like peptides in the wax moth Galleria mellonella. Insect 
Biochem Mol Biol 2008;38:201–212.
 60. shin sW, Park ss, Park ds, Kim MG, Kim sC, Woon shin s, 
Park d- s, Gwang Kim M et  al. Isolation and characterization of 
immune- related genes from the fall webworm, Hyphantria cunea, 
using PCR- based differential display and subtractive cloning. 
Insect Biochem Mol Biol 1998;28:827–837.
 61.  sarauer BL, Gillott C, hegedus d. Characterization of an intes-
tinal mucin from the peritrophic matrix of the diamondback moth, 
Plutella xylostella. Insect Mol Biol 2003;12:333–343.
 62.  Gandhe As, John sh, Nagaraju J, Noduler NJ. Noduler, a novel 
immune up- regulated protein mediates nodulation response in 
insects. J Immunol 2007;179:6943–6951.
 63.  Niere M, Meißlitzer C, dettloff M, Weise C, Ziegler M et al. Insect 
immune activation by recombinant Galleria mellonella apolipo-
phorin III. Biochim Biophys Acta 1999;1433:16–26.
 64. Niere M, dettloff M, Maier t, Ziegler M, Wiesner A. Insect immune 
activation by apolipophorin III is correlated with the lipid- binding 
properties of this protein. Biochemistry 2001;40:11502–11508.
 65.  Zdybicka- Barabas A, Cytryñska M. Apolipophorins and insects 
immune response. ISJ - Invertebr Surviv J 2013;10:58–68.
 66.  Park sY, Kim Ch, Jeong Wh, Lee Jh, seo sJ et al. Effects of two 
hemolymph proteins on humoral defense reactions in the wax 
moth, Galleria mellonella. Dev Comp Immunol 2005.
 67.  Zdybicka- Barabas A, Cytryńska M. Involvement of apolipophorin 
III in antibacterial defense of Galleria mellonella larvae. Comp 
Biochem Physiol B Biochem Mol Biol 2011;158:90–98.
 68.  Zdybicka- Barabas A, Mak P, Jakubowicz t, Cytryńska M. 
Lysozyme and defense peptides as suppressors of phenoloxi-
dase activity in Galleria mellonella. Arch Insect Biochem Physiol 
2014;87:1–12.
 69.  Wojda i. Immunity of the greater wax moth Galleria mellonella. 
Insect Sci 2017;24:342–357.
 70.  sun JN, solis NV, Phan Qt, Bajwa Js, Kashleva h et al. Host cell 
invasion and virulence mediated by Candida albicans Ssa1. PLoS 
Pathog 2010;6:e1001181.
 71.  Cho t, toyoda M, sudoh M, Nakashima Y, Calderone rA et al. Isola-
tion and sequencing of the Candida albicans MSI3, a putative novel 
member of the hsp70 family. Yeast 2003;20:149–156.
 72.  Li Xs, reddy Ms, Baev d, Edgerton M. Candida albicans Ssa1/2p is 
the cell envelope binding protein for human salivary histatin 5. J 
Biol Chem 2003;278:28553–28561.
 73.  Nagao J- ichi, Cho t, Uno J, Ueno K, imayoshi r et al. Candida albi-
cans Msi3p, a homolog of the Saccharomyces cerevisiae Sse1p of 
the hsp70 family, is involved in cell growth and fluconazole toler-
ance. FEMS Yeast Res 2012;12:728–737.
 74.  Urban C, Xiong X, sohn K, schröppel K, Brunner h et al. The moon-
lighting protein Tsa1p is implicated in oxidative stress response 
and in cell wall biogenesis in Candida albicans. Mol Microbiol 
2005;57:1318–1341.
 75.  smagur J, Guzik K, Bzowska M, Kuzak M, Zarebski M et al. Staphy-
lococcal cysteine protease staphopain B (SspB) induces rapid 
engulfment of human neutrophils and monocytes by macrophages. 
Biol Chem 2009;390:361–371.
Edited by: J. Cavet and K. robinson
